Investigation of colistin utilization in the treatment of multidrug-resistant gram-negative nosocomial bloodstream ınfections in children and literature review
European Journal of Pediatrics · 2024
DOI: 10.1007/s00431-024-05607-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pediatrics, 2024. Verfasst von Cankat Genis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Pediatrics, Dr. Sami Ulus Maternity and Children's Research and Training Hospital, Ankara, Turkey. cankatgenis@gmail.com. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Bacteremia, Colistin, Cross Infection. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
This retrospective study aimed to assess the effectiveness and safety of colistin used in combination therapy for treating nosocomial bloodstream infections caused by multi-drug resistant gram-negative pathogens in pediatric patients. Patients aged between 1 month and 18 years consecutively hospitalized with healthcare-associated bloodstream infections necessitating the administration of intravenous colistin at Dr. Sami Ulus Training and Research Hospital between January 2015 and January 2020 were included in the study. Patient-specific detailed clinical information, prognoses, and laboratory findings on days 1, 3, and 7 of colistin treatment were obtained from medical records. The study included 45 pediatric patients receiving intravenous colistin; 26 (57.8%) were male and 19 (42.2%) were female, with a median age of 18 months. While the clinical response was observed at 82.2% and microbiological response at 91.1% with colistin treatment, two patients (4.4%) discontinued treatment due to side effects without assessing treatment response. The most common adverse effect associated with the use of colistin was nephrotoxicity, which occurred in eight patients (17.8%). Among these patients, only one had pre-existing chronic kidney failure. Conclusion: Colistin used in combination therapy may be effective and safe for treating nosocomial infections caused by multi-drug resistant gram-negative bacteria in pediatric patients, who often have high mortality rates and limited treatment options. What is Known: • Colistin is an antibacterial agent used in the treatment of infections caused by multidrug-resistant Gram-negative bacteria (MDR-GNB) and is associated with significant adverse effects such as nephrotoxicity. • The increasing prevalence of hospital-acquired infections has led to the expanded use of colistin in clinical practice. What is New: • The study demonstrates a high clinical and microbiological response rate to combination therapy with colistin in the treatment of infections caused by MDR-GNB. • The study highlights the importance of monitoring nephrotoxicity in pediatric patients receiving colistin, showing that these effects can be reversible after treatment cessation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Pediatrics, Dr. Sami Ulus Maternity and Children's Research and Training Hospital, Ankara, Turkey. cankatgenis@gmail.com.
- Department of Pediatric Infectious Diseases, Dr. Sami Ulus Maternity and Children's Research and Training Hospital, Ankara, Turkey.
- Department of Pediatric Emergency, Dr. Sami Ulus Maternity and Children's Research and Training Hospital, Ankara, Turkey.
Zitieren
APA
Genis, C., Kaman, A., Öztürk, B., & Tanır, G. (2024). Investigation of colistin utilization in the treatment of multidrug-resistant gram-negative nosocomial bloodstream ınfections in children and literature review. European Journal of Pediatrics. https://doi.org/10.1007/s00431-024-05607-2
Vancouver
Genis C, Kaman A, Öztürk B, Tanır G. Investigation of colistin utilization in the treatment of multidrug-resistant gram-negative nosocomial bloodstream ınfections in children and literature review. European Journal of Pediatrics. 2024. doi:10.1007/s00431-024-05607-2
BibTeX
@article{Genis2024,
author = {Genis, Cankat and Kaman, Ayse and Öztürk, Betül and Tanır, Gönül},
title = {Investigation of colistin utilization in the treatment of multidrug-resistant gram-negative nosocomial bloodstream ınfections in children and literature review},
journal = {European Journal of Pediatrics},
year = {2024},
doi = {10.1007/s00431-024-05607-2}
}
EUVIMED